![Sarah Fakih](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Sarah Fakih
Investor Relations Contact chez
EVOTEC SE
Profil
Sarah Fakih is Executive VP & Head-Global Communications, IR at Evotec SE since 2026.
Former roles include Director-Investor Relations at QIAGEN NV, Vice President & Head-Corporate Communications at MorphoSys AG, and Vice President-Investor Relations & Communications at CureVac NV.
Education includes a doctorate from the University of Münster and an MBA from Julius-Maximilians-Universität Würzburg.
Postes actifs de Sarah Fakih
| Sociétés | Poste | Début |
|---|---|---|
| EVOTEC SE | Investor Relations Contact | 01/01/2026 |
Anciens postes connus de Sarah Fakih
| Sociétés | Poste | Fin |
|---|---|---|
| MORPHOSYS AG | Public Communications Contact | - |
| CUREVAC | Investor Relations Contact | - |
| QIAGEN N.V. | Public Communications Contact | - |
Formation de Sarah Fakih
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
16
Relations au 1er degré
6
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 6 |
|---|---|
QIAGEN NV
 QIAGEN NV Medical SpecialtiesHealth Technology Manufactures and distributes sample and assay technology products for pre-analytical sample preparations | Health Technology |
Evotec SE
 Evotec SE Miscellaneous Commercial ServicesCommercial Services Provides drug discovery and development services | Commercial Services |
MorphoSys AG
 MorphoSys AG BiotechnologyHealth Technology Manufactures pharmaceutical products and provides research and development services | Health Technology |
University of Münster
 University of Münster Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Julius-Maximilians-Universität Würzburg
 Julius-Maximilians-Universität Würzburg Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
CureVac NV
 CureVac NV BiotechnologyHealth Technology Operates as a biopharmaceutical company that develops medicines based on messenger ribonucleic acid which includes prophylactic vaccines, oncology, and molecular therapies | Health Technology |
